A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence

Clinical trial NCT04512053 · COMPLETED

Trial details

NCT number: NCT04512053
Sponsor: Taiho Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stress Urinary Incontinence

Start date: 2020-09-04
Primary completion: 2021-12-22
Enrollment: 231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.